Synonyms:

• Flunitrazolam
• 8-Fluoro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
• 8-Fluoro-1-methyl-4H-triazolo-benzodiazepine
• Flunitrazolam Hydrochloride

CAS Number:

• 75617-43-1 (Please verify with the supplier, as CAS numbers may vary)

Molecular Formula:

• C17H12FN3

Molecular Structure:

• (Provide a detailed image of the molecular structure here)

Purity and Grade

Flunitrazolam Pellets are typically available in high purity (≥98%) and are intended for scientific and laboratory use only. These pellets provide a convenient form for controlled dosing and facilitate precise handling in research settings. The purity ensures reliable results when studying the compound’s effects in pharmacological experiments.

Physical and Chemical Properties

• Appearance: White to off-white crystalline pellets or solid tablets
• Molecular Weight: 295.3 g/mol
• Solubility: Flunitrazolam is soluble in organic solvents like ethanol, acetone, and dimethyl sulfoxide (DMSO); it has low solubility in water.
• Melting Point: Not precisely determined for the pellet form
• Boiling Point: Not determined
• Odor: Odorless or faintly aromatic
• Density: Not specifically available

Safety and Handling Information

• Hazards: Flunitrazolam is a benzodiazepine-like compound and may produce sedative, anxiolytic, and CNS-depressant effects. Researchers must handle it with extreme caution and follow appropriate safety protocols. Like other benzodiazepines, it has the potential to cause respiratory depression, sedation, or alterations in behavior if misused.
• Precautions: Always wear protective gloves, goggles, and a lab coat when handling Flunitrazolam. Conduct experiments in a well-ventilated area, such as a fume hood, to avoid inhaling any dust or vapor. Ensure that safety equipment, including eyewash stations and emergency showers, is readily accessible.
• Toxicology: Flunitrazolam’s toxicological data is not fully established, but given its chemical structure and properties, it should be treated as a potentially hazardous substance in research environments. Proper precautions should be taken to avoid exposure.

First-Aid Measures

• Skin Contact: In case of skin contact, immediately wash the affected area with soap and water. If irritation develops, seek medical attention.
• Eye Contact: Rinse eyes immediately with plenty of water for at least 15 minutes. Seek medical attention if discomfort or irritation persists.
• Inhalation: If inhaled, move the person to fresh air immediately. If symptoms such as dizziness, shortness of breath, or coughing occur, seek medical attention.
• Ingestion: Do not induce vomiting. If ingested, seek medical attention immediately. Provide the medical professionals with information about the compound for appropriate treatment.

Usage and Applications

Flunitrazolam is primarily used in neuropharmacological research. As a benzodiazepine derivative, it is studied for its sedative, anxiolytic, and muscle-relaxant properties. The compound is frequently investigated in the context of its CNS depressant effects, and its action on GABA receptors in the brain. Researchers use Flunitrazolam to understand the pharmacodynamics of benzodiazepines and their potential therapeutic applications in anxiety disorders, insomnia, and seizure management.

Some common research applications include:

• GABA receptor modulation studies
• Investigation of anxiolytic (anti-anxiety) effects
• Exploration of sedative and hypnotic properties
• Examination of anticonvulsant and muscle-relaxant effects
• Development of new therapeutic agents for anxiety, insomnia, and related disorders

Storage Conditions

Flunitrazolam Pellets should be stored in a cool, dry place at room temperature (20-25°C). The product should be kept away from light, moisture, and heat. The airtight blister or container should remain sealed until ready for use to preserve the chemical’s stability and prevent degradation. Ensure that it is stored in a secure location to prevent unauthorized access.

Regulatory Information

Flunitrazolam is a research chemical and is not intended for human consumption. The legal status of Flunitrazolam may vary by country or region, and researchers should confirm its legal status in their jurisdiction before purchasing or using it for research. Always ensure compliance with local laws, safety regulations, and ethical guidelines when conducting research with this compound.

FAQ

Q: What is Flunitrazolam used for?
A: Flunitrazolam is primarily used in neuropharmacological research to study its sedative, anxiolytic, and muscle-relaxant effects. It is also used to investigate the pharmacological properties of benzodiazepines and their action on GABA receptors.

Q: Can Flunitrazolam be consumed?
A: No, Flunitrazolam is a research chemical and is not intended for human consumption. It should only be used in controlled laboratory settings by qualified professionals.

Q: How should Flunitrazolam Pellets be stored?
A: Flunitrazolam Pellets should be stored in a cool, dry place at room temperature (20-25°C). They should be kept in an airtight container away from heat, moisture, and light to maintain their stability.

Q: Is Flunitrazolam legal?
A: The legal status of Flunitrazolam varies depending on the country or region. Researchers should verify its legal status in their jurisdiction before purchasing or using it for research.

Introduction

Flunitrazolam is a benzodiazepine derivative that has gained attention in the field of neuropharmacological research. It is a potent sedative and anxiolytic compound, frequently studied for its ability to modulate GABA receptors in the brain. Researchers use Flunitrazolam to explore the pharmacological effects of benzodiazepines and to develop potential treatments for anxiety, insomnia, and other central nervous system (CNS) disorders.